Trending...
- Governor Newsom honors fallen California Highway Patrol Officer Miguel Cano
- Governor Newsom marks historic expansion of California's Film and Television Tax Credit Program, announces 16 new projects to film in the Golden State
- California: Governor Newsom announces appointments 7.2.25
Download
Evernorth, Cigna's health services business, will offer Zerigo's solution as part of a pilot program through its Digital Health Formulary and is the first to launch this new platform for both psoriasis and eczema. (Graphic: Business Wire)
SAN DIEGO--(BUSINESS WIRE)--Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go, today announced the launch of a new software release which includes integration of the American Academy of Dermatology Guideline protocols for the treatment of eczema with narrowband ultraviolet B (NB-UVB) phototherapy.
More on The Californer
Evernorth, Cigna Corporation's health services business, is the first to launch Zerigo's solution for both psoriasis and eczema, which will be offered as a pilot program through its Digital Health Formulary. The Evernorth Digital Health Formulary connects employers, insurers and patients with innovative, affordable, and evidence-based care that meets their broader health care needs. The pilot program will enable more people with chronic skin conditions to better manage their conditions.
"Health plans and self-insured employers are already dealing with rapidly rising specialty drug costs for the treatment of psoriasis, which only affects 3.2% of the population but costs over $20 billion per year with a projected 20% annual growth rate, and now they are facing rising costs for the treatment of eczema," said John Schellhorn, Zerigo's President & CEO. Schellhorn added, "Zerigo is uniquely positioned to help health plans and employers address these rising costs with guideline-recommended therapy and wraparound care support that generates positive health outcomes for members at a small fraction of the cost of these expensive drugs."
With the recent approval of five new specialty drugs indicated for the treatment of eczema and dozens more in development, analysts expect that specialty drug spend for eczema, which affects 7.3% of the U.S. population, will surpass that of psoriasis by the end of the decade.
Zerigo Health's FDA-cleared, natural light therapy solution safely and effectively shifts dermatological care from the clinic to the controlled convenience of home, keeping physicians and their patients with chronic skin conditions connected with personalized data and insights. Patients can easily self-administer clinically proven, American Academy of Dermatology guideline recommended NB-UVB phototherapy using a handheld device and smartphone app. Prescription dosing is controlled via secure cloud-based technology and personalized based on each patient's response to treatment, helping to ensure that patients treat safely in accordance with their physicians' prescriptions. Patients are also remotely monitored and provided personal coaching and support throughout their treatment journey.
"The addition of eczema treatment protocols to our offering is one more significant step toward delivering our vision of empowering every person with a chronic skin condition to live confidently through personalized, connected, and cost-effective care," said Glen Tullman, Executive Chairman of Zerigo Health, CEO of Transcarent, and Managing Director of 7wireVentures. "At such an exciting time in the company's development, we are thrilled to collaborate with Evernorth to provide their members suffering from psoriasis and eczema access to the Zerigo Solution to drive better health outcomes at substantially lower costs than the existing alternatives."
More on The Californer
About Zerigo Health
Zerigo Health offers the only comprehensive home solution that seamlessly connects patients and providers to deliver optimal dermatological outcomes. Zerigo's precision solution remotely treats and monitors patients with chronic skin conditions using narrowband ultraviolet B (NB-UVB) phototherapy, a proven, standard-of-care treatment. Patients benefit from the unique combination of advanced technology with personal coaching and support throughout their treatment journey, which results in documented increases in treatment adherence and patient satisfaction. To learn more, visit www.zerigohealth.com or on LinkedIn or Twitter.
Contacts
Teddy Fulham
teddy.fulham@zerigohealth.com
0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>
Social Media Profiles
Contacts
Teddy Fulham
teddy.fulham@zerigohealth.com
Evernorth, Cigna's health services business, will offer Zerigo's solution as part of a pilot program through its Digital Health Formulary and is the first to launch this new platform for both psoriasis and eczema. (Graphic: Business Wire)
- Evernorth, Cigna's health services business, will offer Zerigo's solution as part of a pilot program through its Digital Health Formulary and is the first to launch this new platform for both psoriasis and eczema. (Graphic: Business Wire)
SAN DIEGO--(BUSINESS WIRE)--Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go, today announced the launch of a new software release which includes integration of the American Academy of Dermatology Guideline protocols for the treatment of eczema with narrowband ultraviolet B (NB-UVB) phototherapy.
More on The Californer
- Utah Metal Fabricator Titan Forge Builds Momentum with Custom Steel Projects and Spiral Staircases
- Jason Koch: Pioneering the Future of Real Estate Development in New Jersey
- Amid Trump's assault on public lands, California conserves over one million acres of land and coastal waters in just one year
- California: Governor Newsom announces appointments 7.7.25
- City of Long Beach to Upgrade Its Internet Infrastructure to Enhance City Network Reliability and Performance
Evernorth, Cigna Corporation's health services business, is the first to launch Zerigo's solution for both psoriasis and eczema, which will be offered as a pilot program through its Digital Health Formulary. The Evernorth Digital Health Formulary connects employers, insurers and patients with innovative, affordable, and evidence-based care that meets their broader health care needs. The pilot program will enable more people with chronic skin conditions to better manage their conditions.
"Health plans and self-insured employers are already dealing with rapidly rising specialty drug costs for the treatment of psoriasis, which only affects 3.2% of the population but costs over $20 billion per year with a projected 20% annual growth rate, and now they are facing rising costs for the treatment of eczema," said John Schellhorn, Zerigo's President & CEO. Schellhorn added, "Zerigo is uniquely positioned to help health plans and employers address these rising costs with guideline-recommended therapy and wraparound care support that generates positive health outcomes for members at a small fraction of the cost of these expensive drugs."
With the recent approval of five new specialty drugs indicated for the treatment of eczema and dozens more in development, analysts expect that specialty drug spend for eczema, which affects 7.3% of the U.S. population, will surpass that of psoriasis by the end of the decade.
Zerigo Health's FDA-cleared, natural light therapy solution safely and effectively shifts dermatological care from the clinic to the controlled convenience of home, keeping physicians and their patients with chronic skin conditions connected with personalized data and insights. Patients can easily self-administer clinically proven, American Academy of Dermatology guideline recommended NB-UVB phototherapy using a handheld device and smartphone app. Prescription dosing is controlled via secure cloud-based technology and personalized based on each patient's response to treatment, helping to ensure that patients treat safely in accordance with their physicians' prescriptions. Patients are also remotely monitored and provided personal coaching and support throughout their treatment journey.
"The addition of eczema treatment protocols to our offering is one more significant step toward delivering our vision of empowering every person with a chronic skin condition to live confidently through personalized, connected, and cost-effective care," said Glen Tullman, Executive Chairman of Zerigo Health, CEO of Transcarent, and Managing Director of 7wireVentures. "At such an exciting time in the company's development, we are thrilled to collaborate with Evernorth to provide their members suffering from psoriasis and eczema access to the Zerigo Solution to drive better health outcomes at substantially lower costs than the existing alternatives."
More on The Californer
- Groflex Named One of the Top 100 Manufacturing Startups in San Francisco by F6S
- BofA Directs Additional $1 Million to Los Angeles Nonprofits for Evolving Fire Recovery Needs
- Introducing LK Blue: The Cool-Girl Denim Brand That's Redefining LA Style Launches E-Commerce
- THINKWARE Announces Prime Day Deals on Best-Selling Dash Cams
- Zeta Sky Strengthens Cybersecurity Support for Ontario Businesses Facing Rising Identity & Complian
About Zerigo Health
Zerigo Health offers the only comprehensive home solution that seamlessly connects patients and providers to deliver optimal dermatological outcomes. Zerigo's precision solution remotely treats and monitors patients with chronic skin conditions using narrowband ultraviolet B (NB-UVB) phototherapy, a proven, standard-of-care treatment. Patients benefit from the unique combination of advanced technology with personal coaching and support throughout their treatment journey, which results in documented increases in treatment adherence and patient satisfaction. To learn more, visit www.zerigohealth.com or on LinkedIn or Twitter.
Contacts
Teddy Fulham
teddy.fulham@zerigohealth.com
0) { // Create container for hi-res image jQuery('#bw-release-hires').append('
'); }; }); ]]>
Social Media Profiles
Contacts
Teddy Fulham
teddy.fulham@zerigohealth.com
Filed Under: Business
0 Comments
Latest on The Californer
- California: TOMORROW: Governor Newsom to join federal, state, and local leaders to recognize six-month anniversary of Los Angeles firestorms
- Skool Alternatives Reddit: Skool vs Circle vs Whop - Did you join one yet?
- Southern Soul Artist Moe Z Releases New Single 'Set It Out' Distributed by Morris Day Entertainment
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
- Green Jacket Gateway" System: Your Definitive Path to Golfing Greatness
- From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
- Luxury Auto Detailing Brings High-End Mobile Car Care to Cherry Valley and Surrounding Areas
- Transgender Visual Artist Debuts New Work
- Stay Cool All Day With BGMgirl Drawstring Half Wigs
- California: Governor Newsom proclaims Independence Day 2025
- Gundam GQuuuuuuX Takes Center Stage at Anime Expo 2025
- John Duffy Competes in Mr Muscle Beach
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- Thorn & Bloom Magazine Unveils Groundbreaking Second Edition: "Breaking the Cycle"
- Cheap O SMS Launches Groundbreaking Free SMS API Service
- California: Governor Newsom signs legislation 7.3.25
- Fireworks, fun, and safety: California preps for the holiday weekend
- BillBoards Inc. Hits the Road with God Bless America Tour and Reality Series Now Streaming on Tubi TV
- Legacy vs. Legacy Gala: Celebrating the Past, Powering the Future of the L.A. Watts Summer Games
- Orion Retreats: Pioneering the Future of Conscious Leadership and Luxury Wellness Tourism